NSE - Delayed Quote INR

Mankind Pharma Limited (MANKIND.NS)

Compare
2,565.95 -81.05 (-3.06%)
At close: 3:30 PM GMT+5:30
All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Operating Cash Flow
21,524,450.00
21,524,450.00
18,133,017.00
9,197,760.00
11,372,440.00
--
Investing Cash Flow
-20,816,903.00
-20,816,903.00
-10,541,287.00
-13,691,430.00
-12,222,110.00
--
Financing Cash Flow
52,656.00
52,656.00
-7,397,281.00
6,046,200.00
-78,110.00
--
End Cash Position
3,820,075.00
3,820,075.00
3,048,207.00
2,830,590.00
1,273,280.00
--
Capital Expenditure
-3,823,368.00
-3,823,368.00
-8,320,690.00
-23,455,230.00
-3,123,160.00
--
Issuance of Debt
4,007,049.00
4,007,049.00
10,985,799.00
12,781,880.00
5,789,410.00
--
Repayment of Debt
-3,667,411.00
-3,667,411.00
-17,938,231.00
-6,539,420.00
-4,684,640.00
--
Free Cash Flow
17,701,082.00
17,701,082.00
9,812,327.00
-14,257,470.00
8,249,280.00
--
3/31/2020 - 5/9/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers